Anti-CD4 Antibody Prevents Chronic Graft-Versus-Host Disease in Mice
Author Information
Author(s): Wang Ziwei, Li Ruiqi, Fu Weijia, Cheng Hui, Zhang Yan, Tang Gusheng, Yang Jianmin, Wang Jianmin, Ni Xiong
Primary Institution: Department of Hematology, Changhai Hospital, The Second Military Medical University, Shanghai, China
Hypothesis
Transient treatment with anti-CD4 mAb supports reconstruction of CD4+CD8+ DP thymocytes and induces immune tolerance in thymus-infiltrating CD8+ T cells.
Conclusion
Anti-CD4 mAb therapy early post-HCT allows thymus recovery and preserves long-term graft-versus-leukemia effect.
Supporting Evidence
- Anti-CD4 mAb treatment improved survival rates in mice post-HCT.
- Mice treated with anti-CD4 showed recovery of thymic function.
- Histopathological analysis indicated reduced tissue damage in anti-CD4 treated mice.
Takeaway
This study shows that giving a special antibody to mice after a transplant helps their immune system recover and prevents a disease that can happen after the transplant.
Methodology
Mice were treated with either IgG or anti-CD4 monoclonal antibody after hematopoietic cell transplantation, and various immune responses were assessed.
Participant Demographics
Male C57BL/6 and BALB/c mice, aged 12 to 14 weeks.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website